Chemokine: receptor structure, interactions, and antagonism
- PMID: 17291188
- DOI: 10.1146/annurev.immunol.24.021605.090529
Chemokine: receptor structure, interactions, and antagonism
Abstract
Chemokines are critical mediators of cell migration during routine immune surveillance, inflammation, and development. Chemokines bind to G protein-coupled receptors and cause conformational changes that trigger intracellular signaling pathways involved in cell movement and activation. Although chemokines evolved to benefit the host, inappropriate regulation or utilization of these proteins can contribute to or cause many diseases. Specific chemokine receptors provide the portals for HIV to get into cells, and others contribute to inflammatory diseases and cancer. Thus, there is significant interest in developing receptor antagonists. To this end, the structures of ligands coupled with mutagenesis studies have revealed mechanisms for antagonism based on modified proteins. Although little direct structural information is available on the receptors, binding of small molecules to mutant receptors has allowed the identification of key residues involved in the receptor-binding pockets. In this review, we discuss the current knowledge of chemokine:receptor structure and function, and its contribution to drug discovery.
Similar articles
-
A burgeoning family of biological mediators: chemokines and chemokine receptors.Arch Immunol Ther Exp (Warsz). 2000;48(3):143-50. Arch Immunol Ther Exp (Warsz). 2000. PMID: 10912618 Review.
-
Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.Adv Protein Chem. 2004;68:351-91. doi: 10.1016/S0065-3233(04)68010-7. Adv Protein Chem. 2004. PMID: 15500866 Review.
-
Recent advances in chemokines and chemokine receptors.Crit Rev Immunol. 1999;19(1):1-47. Crit Rev Immunol. 1999. PMID: 9987599 Review.
-
Chemokine receptor modeling: an interdisciplinary approach to drug design.Future Med Chem. 2014 Jan;6(1):91-114. doi: 10.4155/fmc.13.194. Future Med Chem. 2014. PMID: 24358950 Review.
-
Role of chemokines polymorphisms in diseases.Immunol Lett. 2012 Jul 30;145(1-2):15-22. doi: 10.1016/j.imlet.2012.04.010. Immunol Lett. 2012. PMID: 22698179 Review.
Cited by
-
Structural perspectives on antimicrobial chemokines.Front Immunol. 2012 Dec 28;3:384. doi: 10.3389/fimmu.2012.00384. eCollection 2012. Front Immunol. 2012. PMID: 23293636 Free PMC article.
-
Evaluation of chemokines in gingival crevicular fluid in children with band and loop space maintainers: A clinico-biochemical study.Contemp Clin Dent. 2016 Jul-Sep;7(3):302-6. doi: 10.4103/0976-237X.188542. Contemp Clin Dent. 2016. PMID: 27630491 Free PMC article.
-
Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.J Biol Chem. 2013 May 10;288(19):13522-33. doi: 10.1074/jbc.M113.455329. Epub 2013 Mar 27. J Biol Chem. 2013. PMID: 23536183 Free PMC article.
-
Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.mBio. 2016 May 3;7(3):e00270-16. doi: 10.1128/mBio.00270-16. mBio. 2016. PMID: 27143385 Free PMC article.
-
Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.Int J Mol Sci. 2022 Sep 21;23(19):11070. doi: 10.3390/ijms231911070. Int J Mol Sci. 2022. PMID: 36232381 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical